The European Lung Cancer Virtual Congress (ELCC 2021 Virtual) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.
This year’s meeting featured expert reviews of the current state-of-the-art, as well as updates in lung cancer prevention, screening and detection.
View all videosELCC 2021
VIDEO: Disparities in access to screening and variation of targets in different groups w/ @Dr_AfsanehBarzi of @cityofhope
👉http://ow.ly/BJeI50EhrjD👈
@VJOncology @OncoAlert @ASCO #GI21 #GIsm #OncoAlert #Oncology #ClinOnc #MedOnc
Great news for pts with #bladdercancer. Nice that Trop2 adds target to Nectin4 without complete cross-resistance. Thanks to TROPHY-U01 study teams and esp pts and families. Additional studies ongoing. #blcsm https://twitter.com/pgrivasmdphd/status/1382045931529334784
Breaking news: FDA just gave accelerated approval to sacituzumab govitecan for pretreated advanced urothelial Ca! Huge news for patients & families! TROPHY-U01 trial! @SeattleCCA @DrScottTagawa @neerajaiims @y_loriot @DanielPetrylak @cnsternberg @OncoAlert https://www.streetinsider.com/dr/news.php?id=18256030&gfv=1
FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sacituzumab-govitecan-advanced-urothelial-cancer
@PGrivasMDPhD @apolo_andrea @MattGalsky @garysteinbergmd @ArjunBalarMD @WorldBladderCan @BladderCancerUS
Our Dr. Filip Janku discusses the development of a liquid-phase-based DNA extraction method that enriches for cell-free DNA: https://fal.cn/3eHdp @VJOncology @FilipJankuMD #AACR21 #EndCancer
ELCC 2021
The European Lung Cancer Virtual Congress (ELCC 2021 Virtual) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.
This year’s meeting featured expert reviews of the current state-of-the-art, as well as updates in lung cancer prevention, screening and detection.
View all videosVIDEO: Disparities in access to screening and variation of targets in different groups w/ @Dr_AfsanehBarzi of @cityofhope
👉http://ow.ly/BJeI50EhrjD👈
@VJOncology @OncoAlert @ASCO #GI21 #GIsm #OncoAlert #Oncology #ClinOnc #MedOnc
Great news for pts with #bladdercancer. Nice that Trop2 adds target to Nectin4 without complete cross-resistance. Thanks to TROPHY-U01 study teams and esp pts and families. Additional studies ongoing. #blcsm https://twitter.com/pgrivasmdphd/status/1382045931529334784
Breaking news: FDA just gave accelerated approval to sacituzumab govitecan for pretreated advanced urothelial Ca! Huge news for patients & families! TROPHY-U01 trial! @SeattleCCA @DrScottTagawa @neerajaiims @y_loriot @DanielPetrylak @cnsternberg @OncoAlert https://www.streetinsider.com/dr/news.php?id=18256030&gfv=1
FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sacituzumab-govitecan-advanced-urothelial-cancer
@PGrivasMDPhD @apolo_andrea @MattGalsky @garysteinbergmd @ArjunBalarMD @WorldBladderCan @BladderCancerUS
Our Dr. Filip Janku discusses the development of a liquid-phase-based DNA extraction method that enriches for cell-free DNA: https://fal.cn/3eHdp @VJOncology @FilipJankuMD #AACR21 #EndCancer
